S 55746
CL1-55746-001
Phase 1 small_molecule completed
Quick answer
S 55746 for Chronic Lymphocytic Leukaemia (CLL) is a Phase 1 program (small_molecule) at Servier Laboratories (Aust.) Pty. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Servier Laboratories (Aust.) Pty.
- Indication
- Chronic Lymphocytic Leukaemia (CLL)
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed